Rani Therapeutics
RANI
RANI
15 hedge funds and large institutions have $19.6M invested in Rani Therapeutics in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
15
Holders Change
+15
Holders Change %
–
% of All Funds
0.26%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
15
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
NFGH
1
Nan Fung Group Holdings
Kai Tak,
Hong Kong
|
$8.8M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$5.05M |
3 |
CCM
3
CAAS Capital Management
New York
|
$1.34M |
4 |
4
Goldman Sachs
New York
|
$1.08M |
5 |
5
Squarepoint
New York
|
$891K |
Top Sellers
No sellers this quarter